|Bid||1.27 x 7000|
|Ask||1.35 x 6000|
|Day's Range||1.30 - 1.34|
|52 Week Range||1.30 - 3.49|
|PE Ratio (TTM)||-1.22|
|Earnings Date||May 4, 2017 - May 8, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
Q2 2017 Endocyte Inc Earnings Call
WEST LAFAYETTE, Ind., Aug. 16, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that four posters ...
On a per-share basis, the West Lafayette, Indiana-based company said it had a loss of 28 cents. The biopharmaceutical company posted revenue of $13,000 in the period. The company's shares closed at $1.42. ...